Soler Marta, Feliu Lidia, Planas Marta, Ribas Xavi, Costas Miquel
QBIS-CAT Research Group, Institut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Campus Montilivi, E-17071 Girona, Catalonia, Spain.
LIPPSO, Departament de Química, Universitat de Girona, Campus Montilivi, E-17071 Girona, Catalonia, Spain.
Dalton Trans. 2016 Aug 16;45(33):12970-82. doi: 10.1039/c5dt04529k.
The rich chemical and structural versatility of transition metal complexes provides numerous novel paths to be pursued in the design of molecules that exert particular chemical or physicochemical effects that could operate over specific biological targets. However, the poor cell permeability of metallodrugs represents an important barrier for their therapeutic use. The conjugation between metal complexes and a functional peptide vector can be regarded as a versatile and potential strategy to improve their bioavailability and accumulation inside cells, and the site selectivity of their effect. This perspective lies in reviewing the recent advances in the design of metallopeptide conjugates for biomedical applications. Additionally, we highlight the studies where this approach has been directed towards the incorporation of redox active metal centers into living organisms for modulating the cellular redox balance, as a tool with application in anticancer therapy.
过渡金属配合物丰富的化学和结构多样性为设计具有特定化学或物理化学效应、作用于特定生物靶点的分子提供了众多新途径。然而,金属药物较差的细胞渗透性是其治疗应用的一个重要障碍。金属配合物与功能性肽载体之间的共轭可被视为提高其生物利用度、细胞内积累及其效应位点选择性的一种通用且有潜力的策略。本文旨在综述金属肽共轭物在生物医学应用设计方面的最新进展。此外,我们重点介绍了将氧化还原活性金属中心引入活生物体以调节细胞氧化还原平衡的研究,这是一种应用于抗癌治疗的工具。